Abstract Background Fibrotic Interstitial lung diseases (ILD) are a heterogeneous group of
chronic lung diseases characterized by diverse degrees of lung inflammation and …

Pulmonary fibrosis is the result of various diseases with no satisfactory treatment
approaches. The exosome-mediated transfer of long noncoding RNAs (lncRNAs) has been …

Interstitial lung abnormalities (ILA), incidental findings on computed tomography scans, have
raised concerns due to their association with worse clinical outcomes. Our meta-analysis …

Lung diseases have a significant impact on respiratory health, causing various symptoms
and posing challenges in diagnosis and treatment. This research presents a methodology …

The prevalence of obstructive sleep apnoea (OSA) is continuously increasing in patients
with idiopathic pulmonary fibrosis (IPF) and, for the first time, the recent IPF guidelines …

Persistent inflammation within the respiratory tract underlies the pathogenesis of numerous
chronic pulmonary diseases. There is evidence supporting that chronic lung diseases are …

Background Antibody-drug conjugates have revolutionized cancer therapy due to their
selectivity and efficacy. However, concerns have been raised regarding the potential effects …

Interstitial lung diseases (ILDs) comprise a heterogeneous group of disorders (such as
idiopathic pulmonary fibrosis, sarcoidosis, asbestosis, and pneumonitis) characterized by …

Inspiratory muscle training (IMT) has been described as one of the components of the
treatment of chronic lung conditions such as obstructive and restrictive lung diseases …

Background The current interstitial lung disease (ILD) classification has overlapping clinical
presentations and outcomes. Cluster analysis modeling is a valuable tool in identifying …